Successful Tablet Manufacturing Site Transfer to Bend Bioscience Georgia

A pharma company conducted a risk assessment for potential natural disasters and shipping constraints in their supply chain. As a result of such assessment, the company approached Bend Bioscience to strengthen the company’s supply chain for its immediate-release tablet product. The company made the decision to move manufacturing of its product into the U.S., its biggest market, to reduce supply and revenue risks.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.

  • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.